SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458508101934v1
15/7/811    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Anderson, V.
Right arrow Articles by Miller, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, V.
Right arrow Articles by Miller, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction

VM Anderson

Nuclear Magnetic Resonance Research Unit, Institute of Neurology, University College London, Queen Square, London, UK; Department of Neuroinflammation, Institute of Neurology, University College London, Queen Square, London, UKv.anderson{at}ion.ucl.ac.uk

LK Fisniku

Nuclear Magnetic Resonance Research Unit, Institute of Neurology, University College London, Queen Square, London, UK; Department of Neuroinflammation, Institute of Neurology, University College London, Queen Square, London, UK

DR Altmann

Nuclear Magnetic Resonance Research Unit, Institute of Neurology, University College London, Queen Square, London, UK; Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK

AJ Thompson

Nuclear Magnetic Resonance Research Unit, Institute of Neurology, University College London, Queen Square, London, UK; Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, Queen Square, London, UK

DH Miller

Nuclear Magnetic Resonance Research Unit, Institute of Neurology, University College London, Queen Square, London, UK; Department of Neuroinflammation, Institute of Neurology, University College London, Queen Square, London, UK

Background

Regional atrophy measures may offer useful information about the causes of specific clinical deficits in multiple sclerosis (MS).

Objective

To determine the magnitude of cerebellar gray and white matter (GM and WM) atrophy in patients with clinically isolated syndromes (CIS) and MS, and their role in clinical manifestations of cerebellar damage.

Methods

T1-weighted volumetric magnetic resonance imaging (MRI) of 73 patients [29 CIS, 33 relapsing–remitting MS (RRMS), 11 secondary progressive MS (SPMS)] was compared with 25 controls. GM and WM regions were generated using SPM5 and cerebellar regions delineated. Linear regression was used to investigate differences in tissue-specific cerebellar volumes between groups and the association with clinical measures.

Results

Mean cerebellar GM volume (CGMV) was 100.1 cm3 in controls, 96.4 cm3 in CIS patients, 91.8 cm3 in RRMS patients, and 88.8 cm3 in SPMS patients. Mean cerebellar WM volumes (CWMV) were 21.3 cm3, 20.4 cm3, 19.9 cm3, and 18.8 cm3, respectively. CGMV was reduced by 4.8 cm3 (P = 0.054) in RRMS patients, and 8.5 cm3 (P = 0.012) in SPMS patients, relative to controls. Only patients with SPMS showed a borderline significant reduction in CWMV compared with controls (mean 2.1 cm3, P = 0.053). CGMV was significantly smaller in patients assessed as having cerebellar dysfunction compared with patients who had normal cerebellar function. Significant associations of CGMV and CWMV with performance on the nine-hole peg test were also observed.

Conclusion

Clinically relevant GM atrophy occurs in the cerebellum of MS patients and is more prominent than WM atrophy. As such, it may provide complementary data to other regional atrophy and intrinsic tissue measures.

Key Words: atrophy • cerebellum • gray matter • multiple sclerosis • region of interest

This version was published on July 1, 2009

Multiple Sclerosis, Vol. 15, No. 7, 811-817 (2009)
DOI: 10.1177/1352458508101934


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement